- Home
- SOND vs ACXP Comparison
SOND vs ACXP Comparison
Compare SOND & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOND
- ACXP
- Stock Information
- Founded
- SOND 2014
- ACXP 2017
- Country
- SOND United States
- ACXP United States
- Employees
- SOND N/A
- ACXP N/A
- Industry
- SOND Hotels/Resorts
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SOND Consumer Discretionary
- ACXP Health Care
- Exchange
- SOND Nasdaq
- ACXP Nasdaq
- Market Cap
- SOND 6.8M
- ACXP 6.8M
- IPO Year
- SOND N/A
- ACXP 2021
- Fundamental
- Price
- SOND $0.13
- ACXP $4.75
- Analyst Decision
- SOND
- ACXP Strong Buy
- Analyst Count
- SOND 0
- ACXP 3
- Target Price
- SOND N/A
- ACXP $143.67
- AVG Volume (30 Days)
- SOND 12.0M
- ACXP 82.7K
- Earning Date
- SOND 10-14-2025
- ACXP 11-12-2025
- Dividend Yield
- SOND N/A
- ACXP N/A
- EPS Growth
- SOND N/A
- ACXP N/A
- EPS
- SOND N/A
- ACXP N/A
- Revenue
- SOND $589,133,000.00
- ACXP N/A
- Revenue This Year
- SOND $46.47
- ACXP N/A
- Revenue Next Year
- SOND N/A
- ACXP N/A
- P/E Ratio
- SOND N/A
- ACXP N/A
- Revenue Growth
- SOND N/A
- ACXP N/A
- 52 Week Low
- SOND $0.13
- ACXP $3.80
- 52 Week High
- SOND $4.09
- ACXP $37.00
- Technical
- Relative Strength Index (RSI)
- SOND 20.09
- ACXP 40.51
- Support Level
- SOND $0.13
- ACXP $4.51
- Resistance Level
- SOND $0.26
- ACXP $5.79
- Average True Range (ATR)
- SOND 0.10
- ACXP 0.54
- MACD
- SOND -0.05
- ACXP -0.14
- Stochastic Oscillator
- SOND 0.85
- ACXP 7.50
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.